Dr. Hajarizadeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10100 SE Sunnyside Rd
Clackamas, OR 97015Phone+1 503-571-4120Fax+1 503-571-3069
Education & Training
- UMass Chan Medical SchoolFellowship, Vascular Surgery - Independent, 1993 - 1995
- Oregon Health & Science University (OHSU Health)Residency, Surgery, 1987 - 1993
- Oregon Health and Science University School of MedicineClass of 1987
Certifications & Licensure
- WA State Medical License 1995 - 2026
- OR State Medical License 1988 - 2025
- American Board of Surgery Vascular Surgery
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 62 citationsEffective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate.Homayon Hajarizadeh, Krassi Ivancev, Charles R. Mueller, William S. Fletcher, Eugene A. Woltering
American Journal of Surgery. 1992-05-01 - 18 citationsMidterm outcomes for 605 patients receiving Endologix AFX or AFX2 Endovascular AAA Systems in an integrated healthcare system.Robert W. Chang, Kara A. Rothenberg, Jessica Harris, Rebecca C. Gologorsky, Jeffrey H. Hsu
Journal of Vascular Surgery. 2021-03-01 - 88 citationsInhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent.Rosemary Barrie, Eugene A. Woltering, Homayon Hajarizadeh, Charles Mueller, Tina Ure
The Journal of Surgical Research. 1993-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: